Filter Results:
(133)
Show Results For
- All HBS Web (133)
- Faculty Publications (65)
Show Results For
- All HBS Web (133)
- Faculty Publications (65)
- 1999
- Chapter
The Economics of Drug Discovery
By: Rebecca M. Henderson and Iain Cockburn
Henderson, Rebecca M., and Iain Cockburn. "The Economics of Drug Discovery." Chap. 5 in Pharmaceutical Innovation, edited by Ralph Landau, Basil Achilladelis, and Alexander Scriabine, 308–331. Philadelphia: Chemical Heritage Press, 1999.
- Article
Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
By: Rebecca M. Henderson and Iain Cockburn
Henderson, Rebecca M., and Iain Cockburn. "Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery." Journal of Industrial Economics 46, no. 2 (June 1998): 157–182.
- June 2011 (Revised August 2011)
- Case
Colgate-Palmolive: Staying Ahead in Oral Care
By: Rebecca M. Henderson and Ryan Johnson
In 2011, Colgate-Palmolive (Colgate) was the global leader in oral care, with a dominant market share lead in toothpaste and a growing presence in toothbrushes and mouthwash. However, the firm faced stiff competition with perennial rivals P&G increasing their focus on... View Details
Keywords: Innovation Strategy; Brands and Branding; Product Positioning; Distribution Channels; Relationships; Competition; Competitive Advantage; Customization and Personalization; Health Industry
Henderson, Rebecca M., and Ryan Johnson. "Colgate-Palmolive: Staying Ahead in Oral Care." Harvard Business School Case 311-120, June 2011. (Revised August 2011.)
- Article
Measuring Competence? Exploring Firm Effects in Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
Henderson, Rebecca M., and Ian Cockburn. "Measuring Competence? Exploring Firm Effects in Drug Discovery." Strategic Management Journal 15 (Winter 1994): 63–84. (Winner of Dan and Mary Lou Schendel Best Paper Prize To honor substantial work published in the Strategic Management Journal presented by Strategic Management Society.)
- January 2013 (Revised September 2013)
- Case
Xylem: Let's Solve Water
By: Rebecca M. Henderson and James Weber
Henderson, Rebecca M., and James Weber. "Xylem: Let's Solve Water." Harvard Business School Case 313-082, January 2013. (Revised September 2013.)
- June 2011 (Revised May 2012)
- Case
Procter & Gamble: Marketing Capabilities
By: Rebecca M. Henderson and Ryan Johnson
P&G had become known and recognized as a marketing machine. It was the largest advertiser in the world, with 2010 spending of $8.68 billion. From the company's early exploitation of broadcast media (radio and television) for its soap products to more recent experiments... View Details
Keywords: Advertising; Change Management; Globalized Markets and Industries; Innovation Strategy; Brands and Branding; Marketing Communications; Expansion; Consumer Products Industry
Henderson, Rebecca M., and Ryan Johnson. "Procter & Gamble: Marketing Capabilities." Harvard Business School Case 311-117, June 2011. (Revised May 2012.)
- 1996
- Chapter
The Determinants of Research Productivity in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- Article
The Interactions of Organizational and Competitive Influences on Strategy and Performance
By: Rebecca M. Henderson and Will Mitchell
Henderson, Rebecca M., and Will Mitchell. "The Interactions of Organizational and Competitive Influences on Strategy and Performance." Special Issue on Organizational and Competitive Influences on Strategy and Performance. Strategic Management Journal 18, no. S1 (July 1997): 5–14.
- Article
Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research
By: Rebecca M. Henderson and Iain Cockburn
Henderson, Rebecca M., and Iain Cockburn. "Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research." Journal of Health Economics 20, no. 6 (November 2001): 32–59.
- spring 1996
- Article
Scale, Scope and Spillovers: The Determinants of Research Productifity in Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
Henderson, Rebecca M., and Ian Cockburn. "Scale, Scope and Spillovers: The Determinants of Research Productifity in Drug Discovery." RAND Journal of Economics 27, no. 1 (spring 1996): 32–59.
- January 2012
- Teaching Note
Best Practice in Consumer Packaged Goods Management
By: Rebecca M. Henderson and Ryan Johnson
Keywords: Consumer Products Industry
- June 2011 (Revised May 2012)
- Case
Reckitt Benckiser: Fast and Focused Innovation
By: Rebecca M. Henderson and Ryan Johnson
Since its 1999 merger Reckitt Benckiser (RB), a global consumer goods company, led by its CEO Bart Becht, RB developed a reputation for rapid product innovation and industry leading profit margins. RB's stated strategy was to focus on its Powerbrands and high growth... View Details
Keywords: Mergers and Acquisitions; Global Strategy; Innovation Leadership; Leadership Style; Growth and Development Strategy; Brands and Branding; Product Development; Performance Improvement; Commercialization; Consumer Products Industry
Henderson, Rebecca M., and Ryan Johnson. "Reckitt Benckiser: Fast and Focused Innovation." Harvard Business School Case 311-116, June 2011. (Revised May 2012.)
- 2000
- Chapter
Measuring Competence? Exploring Firm Effects in Drug Discovery
By: Rebecca M. Henderson and Iain Cockburn
Keywords: Competency and Skills; Measurement and Metrics; Research and Development; Innovation and Invention; Pharmaceutical Industry
Henderson, Rebecca M., and Iain Cockburn. "Measuring Competence? Exploring Firm Effects in Drug Discovery." Chap. 6 in The Nature and Dynamics of Organizational Capabilities, edited by Giovanni Dosi, Richard Nelson, and Sidney Winter. New York: Oxford University Press, 2000.
- fall 1994
- Article
Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
Henderson, Rebecca M., and Ian Cockburn. "Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery." Journal of Economics & Management Strategy 3, no. 3 (fall 1994): 481–519.
- January 2002
- Article
Putting Patents in Context: Exploring Knowledge Transfer from MIT
By: Ajay Agrawal and Rebecca M. Henderson
Agrawal, Ajay, and Rebecca M. Henderson. "Putting Patents in Context: Exploring Knowledge Transfer from MIT." Management Science 48, no. 1 (January 2002): 44–60.
- June 2011 (Revised May 2012)
- Case
Nestlé SA: Nutrition, Health and Wellness Strategy
By: Rebecca M. Henderson and Ryan Johnson
In 1997 Nestlé committed to a strategic vision of becoming the leading nutrition, health and wellness (NHW) company in the world. Over the next 13 years, the NHW strategy guided strategic decisions and choices at Nestlé including merger and acquisition choices,... View Details
Keywords: Nutrition; Health; Growth and Development Strategy; Decision Choices and Conditions; Goals and Objectives; Value Creation; Food and Beverage Industry
Henderson, Rebecca M., and Ryan Johnson. "Nestlé SA: Nutrition, Health and Wellness Strategy." Harvard Business School Case 311-119, June 2011. (Revised May 2012.)
- fall 2000
- Article
Putting Patents in Context: Exploring Knowledge Transfer from MIT
By: Rebecca M. Henderson and Ajay Agrawal
Henderson, Rebecca M., and Ajay Agrawal. "Putting Patents in Context: Exploring Knowledge Transfer from MIT." Economic Institutions of Strategy 21 (fall 2000): 1123–1145. (Reprinted in Advances in Strategic Management, Volume 26, Economic Institutions of Strategy," edited by J. Nickerson and B. Silverman, 2009.)
- Article
Inertia and Incentives: Bridging Organizational Economics and Organizational Competence
By: Rebecca M. Henderson and Sarah Kaplan
Henderson, Rebecca M., and Sarah Kaplan. "Inertia and Incentives: Bridging Organizational Economics and Organizational Competence." Organization Science 16, no. 5 (September–October 2005): 509–521.
- Article
Platform Owner Entry and Innovation in Complementary Markets: Evidence from Intel
By: Annabelle Gawer and Rebecca M. Henderson
Gawer, Annabelle, and Rebecca M. Henderson. "Platform Owner Entry and Innovation in Complementary Markets: Evidence from Intel." Journal of Economics & Management Strategy 16, no. 1 (Spring 2007).
- 01 Oct 2021
- News
Tackling the World’s Most Difficult Challenges
2000) in the first days of 2020 to show how Moderna’s considerable investments in AI and other digital tools allowed them to design and deliver a COVID-19 vaccine in just 41 days. Reimagining Capitalism Over the last 15 years, Rebecca... View Details